Novogene Co., Ltd. (688315.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 14.14

From 52W high−0.99%

Volume16.62M

Market capCNY 7.05B

P/E (TTM)42.2x

P/S (TTM)2.8x

Div yield0.30%

Key dataSep 18, 2026

Open

CNY 14.14

From 52W high

−0.99%

Volume

16.62M

Market cap

CNY 7.05B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

18.5x

P/E (TTM)

42.2x

RSI (14)

56.9

MomentumView details →

1D Return

+6.14%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

42.2x

EV/EBITDA

18.5x

EV/Sales

2.7x

P/S (TTM)

2.8x

P/B (TTM)

2.6x

ProfitabilityView details →

Gross Margin

43.04%

Net Margin

7.18%

EBITDA Margin

14.39%

ROE (TTM)

6.07%

ROA (TTM)

4.24%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

+5.56%

EPS YoY

−19.92%

FCF YoY

−33.87%

Revenue CAGR 3Y

+4.69%

EPS CAGR 3Y

−2.33%

EBITDA YoY

—

MomentumView details →

1D Return

+6.14%

YTD Return

—

1Y Return

—

RSI (14)

56.9

vs 50D SMA

+7.26%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

2.62x

Quick Ratio

2.37x

Div Yield

0.30%

Div Rate

CNY 0.05

Div Growth 1Y

−10.00%

EarningsView details →

EPS (Actual)

CNY 0.08

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.00%

Financials snapshotView financials →

Revenue (TTM)

2.26B

Net Income (TTM)

162.52M

Op. CF (TTM)

246.90M

Latest newsMore news →

Novogene announced it will build its first local laboratory in Australia in partnership with Cabrini Health, located at Cabrini Malvern's clinical and cancer research campus in Melbourne, expected to open in 2027.23d ago

Novogene Co., Ltd. announced its semi-annual results for 2026, reporting a net profit attributable to shareholders of 63.1226 million yuan, down 19.82% year-on-year.26d ago

Similar companies

星湖科技600866.SH Lepu Biopharma Co., Ltd.02157.HK Belite Bio, IncBLTE Alkermes plcALKS CARsgen Therapeutics Holdings Limited02171.HK XD昊海生688366.SH Find similar companies →

Latest newsMore news →

Novogene announced it will build its first local laboratory in Australia in partnership with Cabrini Health, located at Cabrini Malvern's clinical and cancer research campus in Melbourne, expected to open in 2027.23d ago Novogene Co., Ltd. announced its semi-annual results for 2026, reporting a net profit attributable to shareholders of 63.1226 million yuan, down 19.82% year-on-year.26d ago